Business

Announcement on the Voluntary Disclosure of Acceptance of the New Drug Application for the Marketing Authorization of Contezolid Acefosamil Sodium for Injection

Announcement on the Voluntary Disclosure of Acceptance of the New Drug Application for the Marketing Authorization of Contezolid Acefosamil Sodium for Injection

articleShanghai Micurx Pharmaceutical Co., Ltd. Class AMay 21, 20254/news/announcement-on-the-voluntary-disclosure-of-acceptance-of-the-new-drug-application-for-the-marketing-authorization-of-contezolid-acefosamil-sodium-for-injection
Announcement on the Voluntary Disclosure of Acceptance of the New Drug Application for the Marketing Authorization of Contezolid Acefosamil Sodium for Injection

About this update from Shanghai Micurx Pharmaceutical Co., Ltd. Class A

Announcement on the Voluntary Disclosure of Acceptance of the New Drug Application for the Marketing Authorization of Contezolid Acefosamil Sodium for InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Micurx Pharmaceutical Co., Ltd. Class A